Literature DB >> 3038368

Desensitization of postjunctional alpha 1- and alpha 2-adrenergic receptor-mediated vasopressor responses in rat harboring pheochromocytoma.

G Tsujimoto, K Honda, B B Hoffman, K Hashimoto.   

Abstract

Prolonged stimulation of tissues by adrenergic agonists may lead to diminished responsiveness of the tissues to subsequent activation by catecholamines; this phenomenon has been termed desensitization or tachyphylaxis. We have examined the in vivo consequences of prolonged stimulation of vascular alpha-adrenergic receptors in rats harboring pheochromocytoma, a tumor that secretes catecholamines. In both early (3-4 weeks after implantation) and late (6-7 weeks after implantation) stages of tumor development, New England Deaconess Hospital rats with transplanted pheochromocytomas developed hypertension and tachycardia and had plasma dopamine and norepinephrine concentrations markedly greater than controls. In both these stages of pheochromocytoma, pressor responses to several vasoconstrictors were examined after pithing. Rats with the tumor were found to become progressively subsensitive to alpha-adrenergic agonists. In the early phase of pheochromocytoma, loss in sensitivity was found for both alpha 1- and alpha 2-adrenergic agonists, whereas responsiveness to the nonadrenergic vasoconstrictors Arg-vasopressin and angiotensin-II was intact (homologous desensitization). However, in the later stage of pheochromocytoma, pressor responses to all these vasoconstrictive agents and also to stimulation of the complex sympathetic outflow were found to be subsensitive (heterologous desensitization). In plasma membranes prepared from mesenteric arteries of early stage tumor-bearing rats, [3H]prazosin binding sites were significantly decreased to 150 +/- 12 fmol/mg vs. 234 +/- 19 fmol/mg in controls. [3H]Yohimbine binding sites were not significantly altered. Our results show that both postjunctional alpha 1- and alpha 2-adrenergic receptor-mediated vasopressor responses can be specifically attenuated in the presence of chronically elevated endogenous catecholamine levels produced by pheochromocytoma and that each alpha-receptor subtype may be differently regulated in the development of desensitization.

Entities:  

Mesh:

Substances:

Year:  1987        PMID: 3038368     DOI: 10.1161/01.res.61.1.86

Source DB:  PubMed          Journal:  Circ Res        ISSN: 0009-7330            Impact factor:   17.367


  9 in total

1.  Hypertension in pheochromocytoma: characteristics and treatment.

Authors:  Samuel M Zuber; Vitaly Kantorovich; Karel Pacak
Journal:  Endocrinol Metab Clin North Am       Date:  2011-06       Impact factor: 4.741

2.  Impact of the human circadian system, exercise, and their interaction on cardiovascular function.

Authors:  Frank A J L Scheer; Kun Hu; Heather Evoniuk; Erin E Kelly; Atul Malhotra; Michael F Hilton; Steven A Shea
Journal:  Proc Natl Acad Sci U S A       Date:  2010-11-08       Impact factor: 11.205

3.  Phaeochromocytoma: a catecholamine and oxidative stress disorder.

Authors:  K Pacak
Journal:  Endocr Regul       Date:  2011-04

4.  Normotensive pheochromocytoma: institutional experience.

Authors:  Amit Agarwal; Sushil Gupta; Anand Kumar Mishra; Nikhil Singh; Saroj K Mishra
Journal:  World J Surg       Date:  2005-09       Impact factor: 3.352

Review 5.  Pheochromocytoma as a Clinical Model of Peripheral Sympathetic Overdrive: Old and New Findings.

Authors:  Guido Grassi; Fosca Quarti Trevano; Raffaella Dell'Oro; Gino Seravalle; Giuseppe Mancia
Journal:  Curr Hypertens Rep       Date:  2019-10-10       Impact factor: 5.369

6.  In vivo desensitization of glycogenolysis to Ca2+-mobilizing hormones in rat liver cells.

Authors:  G Tsujimoto; A Tsujimoto; K Kato; K Hashimoto
Journal:  J Clin Invest       Date:  1988-12       Impact factor: 14.808

7.  Gender-related differences in the clinical presentation of malignant and benign pheochromocytoma.

Authors:  Edwin W Lai; Shiromi M Perera; Bas Havekes; Henri J L M Timmers; Frederieke M Brouwers; Beverly McElroy; Karen T Adams; Shoichiro Ohta; Robert A Wesley; Graeme Eisenhofer; Karel Pacak
Journal:  Endocrine       Date:  2008-11-04       Impact factor: 3.633

8.  Recurrent urosepsis and cardiogenic shock in an elderly patient with pheochromocytoma.

Authors:  Joan Joo-Ching Khoo; Vanessa Shu-Chuan Au; Richard Yuan-Tud Chen
Journal:  Case Rep Endocrinol       Date:  2011-09-06

9.  Clinical Presentation and Outcomes of Phaeochromocytomas/Paragangliomas in Neurofibromatosis Type 1.

Authors:  Ahmed Al-Sharefi; Usman Javaid; Petros Perros; John Ealing; Peter Truran; Sath Nag; Shafie Kamaruddin; Kamal Abouglila; Fiona Cains; Lauren Lewis; Robert Andrew James
Journal:  Eur Endocrinol       Date:  2019-08-16
  9 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.